Study of an anti-inflammatory drug for knee osteoarthritis
Part of Bones, joints & muscles clinical trials.
This study tests an experimental drug given by vein that may block a protein linked to inflammation, which could help reduce knee pain and swelling. It is an early-stage trial to see if the drug is safe and feasible for people with knee osteoarthritis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have knee osteoarthritis confirmed by a doctor.
- Your knee pain is at least 5 on a 0-10 scale.
- Your knee shows signs of swelling (joint effusion).
- You have not had a steroid injection in the knee in the last 3 months.
- You have not had other knee injections (like gel shots) in the last 6 months.
- You have not had a serious infection in the last year, and you do not have conditions like rheumatoid arthritis, fibromyalgia, or uncontrolled diabetes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new antibody drug (FB1003) for people with knee osteoarthritis pain. It will check if the drug is safe and helps reduce pain. You may be eligible if you have moderate to severe knee pain and are willing to temporarily stop your usual pain medications.
This study tests a new injection for knee osteoarthritis that aims to improve pain and function. It may help if you have moderate to severe knee pain that hasn't been relieved by first-line treatments.
This trial studies knee tissue to find better ways to diagnose early osteoarthritis. It may help people who need a knee injection for pain relief.
This study tests a new investigational medicine injected into the knee to see if it is safe and tolerable for people with painful knee osteoarthritis. It may help reduce pain and improve knee function.
This trial tests a new injection called AVD275 for people with knee osteoarthritis. It aims to see if the injection is safe and how it works in the body.
This trial tests an injectable medication called RAB001 for people with knee osteoarthritis that hasn't improved with other treatments. The goal is to see if it's safe and helps reduce pain.
Hear when a new Knee Osteoarthritis (Knee OA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.